Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Clinical Trial of Two Candidate Azoles (Ketoconazole and Posaconazole) for Patients With Recurrent High Grade Glioma

NCT03763396 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03763396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03763396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Clinical Trial of Two Candidate Azoles (Ketoconazole and Posaconazole) for Patients With Recurrent High Grade Glioma
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 1, 2024
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, recurrent, cancer, advanced, glioma of brain